What Happened?
Waltham, MA-based Apogee Therapeutics Appointed Rebecca Dabora as Chief Technology Officer
About the Company
Apogee Therapeutics is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and other inflammatory and immunology indications with high unmet need. Apogee`s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. The company`s two most advanced programs are APG777 and APG808, which are being initially developed for the treatment of AD and COPD, respectively. Based on a broad pipeline and depth of expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today`s standard of care.
About the Person
Rebecca Dabora is Chief Technology Officer at Apogee Therapeutics. Previously, Rebecca held various senior IT leadership roles in the industry.
Info Source
News
Short Profile